Wegovy

N/A

Manufactured by Novo Nordisk

37,587 FDA adverse event reports analyzed

Last updated: 2026-05-19

About Wegovy

Wegovy is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Novo Nordisk. The most commonly reported adverse reactions for Wegovy include NAUSEA, VOMITING, DIARRHOEA, OFF LABEL USE, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for Wegovy.

Top Adverse Reactions

NAUSEA2,654 reports
VOMITING1,898 reports
DIARRHOEA1,279 reports
OFF LABEL USE1,157 reports
FATIGUE1,004 reports
CONSTIPATION859 reports
HEADACHE783 reports
DIZZINESS745 reports
WEIGHT INCREASED742 reports
DRUG INEFFECTIVE682 reports
DECREASED APPETITE645 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION627 reports
ABDOMINAL PAIN589 reports
WEIGHT DECREASED583 reports
ABDOMINAL PAIN UPPER554 reports
DYSPNOEA542 reports
PAIN541 reports
MALAISE526 reports
ILLNESS491 reports
ANXIETY478 reports
DEHYDRATION472 reports
INJECTION SITE PAIN458 reports
ARTHRALGIA440 reports
WEIGHT LOSS POOR432 reports
DEPRESSION404 reports
ASTHENIA378 reports
CONDITION AGGRAVATED364 reports
INCREASED APPETITE364 reports
HUNGER342 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS340 reports
DEVICE MALFUNCTION337 reports
FALL333 reports
DYSPEPSIA332 reports
IMPAIRED GASTRIC EMPTYING329 reports
COUGH325 reports
PRODUCT USE IN UNAPPROVED INDICATION324 reports
PRODUCT USE ISSUE317 reports
PANCREATITIS314 reports
BACK PAIN306 reports
ACUTE KIDNEY INJURY302 reports
COVID 19302 reports
INJECTION SITE EXTRAVASATION300 reports
INSOMNIA296 reports
INJECTION SITE HAEMORRHAGE293 reports
PRODUCT DOSE OMISSION ISSUE283 reports
DRUG INTERACTION281 reports
PAIN IN EXTREMITY275 reports
DEVICE LEAKAGE274 reports
ABDOMINAL DISCOMFORT267 reports
PYREXIA262 reports
ABDOMINAL DISTENSION259 reports
PRODUCT COMMUNICATION ISSUE252 reports
HYPERTENSION251 reports
GASTROOESOPHAGEAL REFLUX DISEASE249 reports
CHEST PAIN248 reports
NASOPHARYNGITIS241 reports
INJECTION SITE DISCHARGE240 reports
FEELING ABNORMAL237 reports
CHOLELITHIASIS235 reports
PRURITUS235 reports
HYPOGLYCAEMIA234 reports
ERUCTATION232 reports
GASTROINTESTINAL DISORDER232 reports
ADVERSE DRUG REACTION225 reports
MYALGIA222 reports
BLOOD GLUCOSE INCREASED220 reports
BLOOD PRESSURE INCREASED220 reports
RASH219 reports
ASTHMA217 reports
URINARY TRACT INFECTION216 reports
PALPITATIONS215 reports
MIGRAINE214 reports
HYPOTENSION211 reports
MUSCLE SPASMS211 reports
OPTIC ISCHAEMIC NEUROPATHY205 reports
VISUAL IMPAIRMENT203 reports
SUICIDAL IDEATION201 reports
HEART RATE INCREASED198 reports
INJECTION SITE BRUISING190 reports
COUNTERFEIT PRODUCT ADMINISTERED189 reports
INCORRECT DOSE ADMINISTERED189 reports
LOSS OF CONSCIOUSNESS188 reports
DEPRESSED MOOD187 reports
PARAESTHESIA186 reports
VISION BLURRED185 reports
HYPERHIDROSIS181 reports
ALOPECIA178 reports
INFLUENZA177 reports
NASAL CONGESTION177 reports
OROPHARYNGEAL PAIN177 reports
SYNCOPE172 reports
CHILLS171 reports
STRESS170 reports
FLATULENCE168 reports
ATRIAL FIBRILLATION165 reports
SURGERY161 reports
ALLODYNIA157 reports
URTICARIA154 reports
FOOD CRAVING152 reports
MATERNAL EXPOSURE DURING PREGNANCY146 reports

Report Outcomes

Out of 19,946 classified reports for Wegovy:

  • Serious: 12,081 reports (60.6%) — includes hospitalization, disability, life-threatening events, or death
  • Non-Serious: 7,865 reports (39.4%)
Serious 60.6%Non-Serious 39.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female13,087 (73.6%)
Male4,667 (26.3%)
Unknown23 (0.1%)

Reports by Age

Age 51358 reports
Age 55341 reports
Age 61325 reports
Age 54316 reports
Age 53298 reports
Age 50293 reports
Age 59291 reports
Age 58289 reports
Age 52287 reports
Age 63286 reports
Age 62284 reports
Age 57277 reports
Age 42267 reports
Age 60265 reports
Age 64263 reports
Age 56262 reports
Age 44238 reports
Age 40237 reports
Age 43234 reports
Age 65233 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with Wegovy?

This profile reflects 37,587 FDA FAERS reports that mention Wegovy. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for Wegovy?

Frequently reported terms in FAERS include NAUSEA, VOMITING, DIARRHOEA, OFF LABEL USE, FATIGUE, CONSTIPATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures Wegovy?

Labeling and FAERS entries often list Novo Nordisk in connection with Wegovy. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.